• Pfizer Inc. (PFE) Forms $100 Million Research Partnership with Boston-Area Schools and Hospitals More...

• Halozyme Therapeutics, Inc. (HALO) and Intrexon Corporation Licensing Deal Valued at $63 Million More...

• Isconova Enters into Adjuvant License Agreement with Crucell N.V. (CRXL) More...

• Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Co-Development of Second Antibody-Drug Conjugate (ADC) Under Existing Collaboration More...

• The Juvenile Diabetes Research Foundation and Selecta Biosciences, Inc. Enter Research Collaboration for Vaccines for Type 1 Diabetes More...

• Ambit Biosciences Withdraws IPO More...

• Access Scientific Completes $10 Million Financing Round More...

• Avantium Raises $43.9 Million to Advance YXY Technology More...

• Stratos Genomics Announces Financing for Validation of SBX(TM) Genome Sequencing Technology More...

• Northwest Biotherapeutics (NWBT) Announces Change and Expansion of Management Team: New CEO, COO, CSO and Senior VP More...

• NovaDel Pharma (NVD) Announces Changes in Management; CFO Resigns More...

• Gerry A. Higgins, Ph.D. Joins GenomeQuest, Inc. to Foster Development of Whole Genome Diagnostics More...

• PURE Bioscience (PURE) Names Craig Johnson as Chief Financial Officer More...

• Selecta Biosciences, Inc. Appoints Peter Keller as Vice President of Business Development and Alliance Management More...



• Enzo Biochem (ENZ) Schedules Teleconference to Discuss Fiscal Third Quarter Results on June 10, 2011 at 8:30 AM E.T. More...

• Pall Corporation (PLL) Reports Strong Third Quarter Results More...

• Repligen Corporation (RGEN) Reports Fourth Quarter and Fiscal Year 2011 Financial Results and Updates Expectations and Corporate Goals for Fiscal Year 2012 More...

• UCB SA Pleads Guilty to Illegal Off-Label Marketing of Epilepsy Drug Keppra; to Pay $34.4 Million More...

• Regenicin, Inc. (RGIN.OB) Announces Dismissal of Lawsuit More...



• U.S. District Court Rules in Favor of Eli Lilly and Company (LLY) in Amylin Pharmaceuticals, Inc. (AMLN) Litigation More...

• Regenicin, Inc. (RGIN.OB) Announces Advanced Discussions With Developers to Establish New Facilities in Florida More...

• France Suspends Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos and Competact Over Bladder Cancer Concerns More...

• FDA Announces New Limits On Merck & Co., Inc. (MRK)'s High-Dose Simvastatin (Zocor) More...

• Vertex Pharmaceuticals (MA) (VRTX) Slides as Cystic Fibrosis Drug Shows Promise but Also Raises Questions in Phase II Trial; Stock Falls 5.14 (9.67%) 12:56PM EDT More...

• Novartis AG Vaccine Shields Against Meningitis Cause More...

• XOMA (US) LLC (XOMA) Announces Phase 2a Six-Month Top Line Trial Results Support Safety and Biological Activity More...

• Abbott Laboratories (ABT) Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease More...

• Biomet Inc. (BMET) Announces Results of Phase I Clinical Trial for Critical Limb Ischemia Utilizing Autologous Concentrated Bone Marrow Aspirate More...

• Pill to Mend a Broken Heart 'Developed by Scientists' - University College London Study More...

• Concerns About High Folate Levels, National Institutes of Health (NIH) Study More...

• Immunomedics, Inc. (IMMU) Reports Advances With New Imaging Agent Developments for Positron Emission Tomography More...

• Respira Therapeutics Introduces Breakthrough Solutions For Respiratory Diseases More...

• Vitrolife: Clinical Study with Good Results Using STEEN Solution(TM) Published in Prestigious Scientific Journal More...